nattjour – Vetenskap och Hälsa
https://www.vetenskaphalsa.se/tag/nattjour/ - 2026-06-05
Filetype
https://www.vetenskaphalsa.se/tag/nattjour/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/bioelektronik/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/kostfett/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/nfl/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/replikation/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/signifikans/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/ssrd/ - 2026-06-05
https://www.vetenskaphalsa.se/tag/talarjamforelse/ - 2026-06-05
Letter from the Director As some of you already know, the faculty has made an analysis of what is required to secure the long-term organisational and economic stability of CEC. A report by Michael Calner, as well as comments on the report by CEC, was recently discussed in the faculty leadership group (“ledningsrådet”). A short summary of that meeting is that the faculty leadership as well as the h
https://www.cec.lu.se/staff-pages/staff-newsletters/february-6th-2020 - 2026-06-05
OBJECTIVE - To study the effect of the short-acting insulin secretagogue nateglinide in patients with maturity-onset diabetes of the young type 3 (MODY3), which is characterized by a defective insulin response to glucose and hypersensitivity to sulfonylureas. RESEARCH DESIGN AND METHODS - We compared the acute effect of nateglinide, glibenclamide, and placebo on prandial plasma glucose and serum i
https://www.vetenskaphalsa.se/tag/medfott-hjartfel/ - 2026-06-06
https://www.vetenskaphalsa.se/tag/coronapandemi/ - 2026-06-06
https://www.vetenskaphalsa.se/tag/torra-slemhinnor/ - 2026-06-06
https://www.vetenskaphalsa.se/tag/bifidobakterier/ - 2026-06-07